These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 9408692)

  • 1. Unexpectedly low immunocompetence in transplant patients on ketoconazole.
    Watanabe T; Gao ZH; Shinozuka N; Schulick RD; Kuo A; Burdick JF
    Clin Transplant; 1997 Dec; 11(6):599-603. PubMed ID: 9408692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Conversion from +Sandimmune to Neoral in kidney transplant recipients treated with cyclosporine and ketoconazole].
    Videla C; Vega J; Borja H; Gatica A; Clavero R; Aldunate T
    Rev Med Chil; 1997 Apr; 125(4):438-45. PubMed ID: 9460285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of ketoconazole on cyclosporine dose in healthy dogs.
    Dahlinger J; Gregory C; Bea J
    Vet Surg; 1998; 27(1):64-8. PubMed ID: 9449179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prednisone metabolism in recipients of kidney or liver transplants and in lung recipients receiving ketoconazole.
    Jeng S; Chanchairujira T; Jusko W; Steiner R
    Transplantation; 2003 Mar; 75(6):792-5. PubMed ID: 12660503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of plasma lipid on pharmacokinetics of ciclosporin and its relationship with plasma prednisolone level in renal transplant patients.
    Sugioka N; Kokuhu T; Okamoto M; Yoshimura N; Ito Y; Shibata N; Takada K
    J Pharm Pharmacol; 2006 Sep; 58(9):1193-200. PubMed ID: 16945177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Combination of cyclosporin and ketoconazole in immunosuppression schemes in patients with transplanted kidney].
    Treĭvish VS; Shoĭkhet IN; Ankova EV
    Klin Med (Mosk); 1998; 76(1):40-2. PubMed ID: 9532915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimal dose and target trough level in cyclosporine and tacrolimus conversion in renal transplantation as evaluated by lymphocyte drug sensitivity and pharmacokinetic parameters.
    Takeuchi H; Okuyama K; Konno O; Jojima Y; Akashi I; Nakamura Y; Iwamoto H; Hama K; Iwahori T; Uchiyama M; Ashizawa T; Matsuno N; Nagao T; Hirano T; Oka K
    Transplant Proc; 2005 May; 37(4):1745-7. PubMed ID: 15919452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinical impact of 1:1 conversion from Neoral to a generic cyclosporine (Gengraf) in renal transplant recipients with stable graft function.
    Qazi YA; Forrest A; Tornatore K; Venuto RC
    Clin Transplant; 2006; 20(3):313-7. PubMed ID: 16824147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of single-dose ezetimibe and steady-state cyclosporine in renal transplant patients.
    Bergman AJ; Burke J; Larson P; Johnson-Levonas AO; Reyderman L; Statkevich P; Maxwell SE; Kosoglou T; Murphy G; Gottesdiener K; Robson R; Paolini JF
    J Clin Pharmacol; 2006 Mar; 46(3):328-36. PubMed ID: 16490809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of measured trough levels and abbreviated AUC estimation by limited sampling strategies for monitoring mycophenolic acid exposure in stable heart transplant patients receiving cyclosporin A-containing and cyclosporin A-free immunosuppressive regimens.
    Dösch AO; Ehlermann P; Koch A; Remppis A; Katus HA; Dengler TJ
    Clin Ther; 2006 Jun; 28(6):893-905. PubMed ID: 16860172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic and pharmacodynamic correlations of cyclosporine therapy in stable renal transplant patients: evaluation of long-term target C(2).
    Brunet M; Campistol JM; Millán O; Vidal E; Esforzado N; Rojo I; Jiménez O; Oppenheimer F; Corbella J; Martorell J
    Int Immunopharmacol; 2003 Jul; 3(7):987-99. PubMed ID: 12810356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C2 is an age-independent parameter for optimal cyclosporine exposure in long-term kidney transplant recipients.
    Ferraresso M; Citterio F; Ghio L; Romagnoli J; Edefonti A; Berardinelli L; Castagneto M
    Transplant Proc; 2004 Nov; 36(9):2656-8. PubMed ID: 15621115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelin-1 plasma levels and hypertension in cyclosporine-treated renal transplant patients.
    Cauduro RL; Costa C; Lhulier F; Garcia RG; Cabral RD; Gonçalves LF; Manfro RC
    Clin Transplant; 2005 Aug; 19(4):470-4. PubMed ID: 16008590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclosporine trough levels in renal graft recipients.
    Jauhari H; Wadhawan S; Yashpal ; Kumar A
    J Indian Med Assoc; 1999 Nov; 97(11):476-7. PubMed ID: 10638120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunosuppression in live-related donor renal transplantation.
    Iman A; Rao M; Juneja R; Jacob CK
    Natl Med J India; 2001; 14(2):75-80. PubMed ID: 11396322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between cyclosporine concentration and genetic polymorphisms of CYP3A5 and MDR1 during the early stage after renal transplantation.
    Azarpira N; Aghdaie MH; Behzad-Behbahanie A; Geramizadeh B; Behzadi S; Malekhoseinie SA; Raisjalal GH; Rahsaz M; Pourgholami A; Sagheb F
    Exp Clin Transplant; 2006 Jun; 4(1):416-9. PubMed ID: 16827636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatotoxicity associated with cyclosporine monitoring using C2 recommendations in adults renal recipients receiving ketoconazole.
    Videla C; Vega J; Borja H
    Transplant Proc; 2005 Apr; 37(3):1574-6. PubMed ID: 15866677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paradoxical cyclosporine A requirements in pediatric renal transplants receiving high-dose steroids.
    Hardy KW; Crocker JF; McLellan H; Goralski KB; Renton KW; Acott PD
    J Clin Pharmacol; 2005 Feb; 45(2):161-7. PubMed ID: 15647408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of pharmacokinetics of mycophenolic acid and its glucuronide between patients with lupus nephritis and with kidney transplantation.
    Mino Y; Naito T; Matsushita T; Otsuka A; Ushiyama T; Ozono S; Hishida A; Kagawa Y; Kawakami J
    Ther Drug Monit; 2008 Dec; 30(6):656-61. PubMed ID: 18978521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The interaction between antiretroviral agents and tacrolimus in liver and kidney transplant patients.
    Jain AK; Venkataramanan R; Shapiro R; Scantlebury VP; Potdar S; Bonham CA; Ragni M; Fung JJ
    Liver Transpl; 2002 Sep; 8(9):841-5. PubMed ID: 12200788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.